Innovative Health Receives FDA Clearances to Reprocess St. Jude Medical’s Advisor™ FL, Two Medtronic Diagnostic Catheters and Biosense Webster’s DECANAV®.

PHOENIX–(BUSINESS WIRE)–Innovative Health, a national leader in medical device reprocessing for the cardiology sector, announced it has received FDA clearances to reprocess the Advisor FL Circular Mapping Catheter, Medtronic’s Torqr™ and Marinr™, and Biosense Webster’s DECANAV. Three of these clearances were received within the last month alone. Innovative Health has already […]

New Harmonized Outcome Measures for Atrial Fibrillation Published in HeartRhythm

BOSTON, Nov. 15, 2018 /PRNewswire/ — OM1, a leading health outcomes and technology company, today announced the publication of new harmonized outcome measures for atrial fibrillation (AF) in HeartRhythm.  OM1’s Richard Gliklichand Michelle Leavy collaborated on the development of the measures and co-authored the publication. The work was funded by the Agency for Healthcare Research and Quality (AHRQ) through an […]

Customer evaluation of CADScor®System compares favorably against existing methods

Interim Report, January – September 2018 Malmö, November 14, 2018 Customer evaluation of CADScor®System compares favorably against existing methods “During the quarter we proudly reported that Kristianstad Central Hospital in Sweden evaluated the CADScor®System with a positive outcome. Due to the good result the hospitals clinical management team has now […]

BioSig Technologies Announces New Research Program with Mayo Clinic

Santa Monica, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company entered into a new advanced research agreement with Mayo […]

GENETIC-AF Phase 2B Clinical Trial Atrial Fibrillation Burden (AFB) Results Presented at American Heart Association 2018 Scientific Sessions

WESTMINSTER, Colo., Nov. 12, 2018 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that data from the Atrial Fibrillation Burden (AFB) substudy of the Phase 2B GENETIC-AF clinical trial were presented November 11, 2018 in a poster session at […]

AliveCor’s Mobile ECG Technology Could Enable More Rapid Diagnosis and Treatment of Heart Attacks

MOUNTAIN VIEW, Calif., Nov. 12, 2018 /PRNewswire/ — AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, has announced that a research version of its mobile technology can identify ST-elevation myocardial infarction (STEMI), the most severe form of heart attack. The findings of the ST LEUIS International Multicenter Study, to be announced at […]

Cardiva Medical Announces Positive Results of the AMBULATE Pivotal Study Evaluating the VASCADE MVP System Compared to Manual Compression for Multi-Vessel Closure Following Electrophysiology Procedures

SANTA CLARA, Calif. & CHICAGO–(BUSINESS WIRE)–Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced that VASCADE® MVP, the first vascular closure system designed specifically for multi-access venous closure following electrophysiology procedures such as arrhythmia ablation, met its endpoints compared to manual compression in a pivotal clinical […]

InCarda Therapeutics Provides Corporate Update Highlighting Fundraising and Clinical Development Milestones

SAN FRANCISCO, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) — InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today provided a corporate update highlighting fundraising and clinical development milestones.  These achievements have contributed to the continued successful development of its lead clinical program, while […]

Orchestra BioMed™ Announces AHA 2018 Presentation on BackBeat® Cardiac Neuromodulation Therapy (CNT)

NEW HOPE, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing advanced therapeutic solutions to address major unmet medical needs, announced today that Professor Petr Neuzil, M.D., Head of the Department of Cardiology of Na Homolce Hospital in Prague, Czech […]

HeartSciences Showcases MyoVista® Wavelet ECG at 2018 Scientific Sessions of the American Heart Association (AHA)

SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, a medical device company developing next generation ECG devices using continuous wavelet transform (CWT) signal processing, is proud to announce its participation as an exhibitor at the upcoming 2018 Scientific Sessions of the American Heart Association (AHA). The AHA Congress will take place November 10-12, 2018 at […]